Flo Health, the world’s leading women’s health app, has announced its plans to expand its operations in Lithuania. The company, which reached unicorn status earlier this year, will add 130 new positions as part of its next growth phase.

Co-created with over 120 doctors and health experts, Flo Health, which maintains offices in Lithuania and the UK with a combined workforce of over 350 employees, serves a global all-in-one platform that offers curated cycle and ovulation tracking. After raising more than $200M in Series C investment in July 2024, Flo’s valuation reached $1 billion, making it the first purely digital consumer women’s health app to achieve unicorn status.

Since establishing its Lithuanian presence in 2020, Flo has grown to become a major force in women’s health technology, with 70M monthly active users and 380M downloads worldwide. Lithuania’s talent pool makes it an ideal location for expansion: after all, the country leads the EU with 64% of women in science and technology.

The expansion of the Vilnius office will leverage the expertise found in the country’s vibrant tech landscape to strengthen capabilities across engineering, product development, and marketing functions. Key focus areas include expanding the user base, advancing tech-driven personalization, and reinforcing privacy and security efforts.

Notably, Flo is the first and only female health app to achieve dual certification in both Privacy and Security ISO standards.